Back to search

The impact of attaining a minimal disease state after high‐dose melphalan and autologous transplantation for multiple myeloma

Data up to Jan 2025

Published2001
Citations114
References24

Total Citations Per Year

Abstract

References (24)

A PROSPECTIVE, RANDOMIZED TRIAL OF AUTOLOGOUS BONE MARROW TRANSPLANTATION AND CHEMOTHERAPY IN MULTIPLE MYELOMA

2013 • 2,176 citations

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

1998 • 1,551 citations

Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple Myeloma

1997 • 576 citations

HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA

1983 • 515 citations

Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

1999 • 499 citations

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study

2000 • 317 citations

Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic Cells

1999 • 253 citations

High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.

1994 • 223 citations

INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION

1989 • 204 citations

INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA

1989 • 198 citations

Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma

1995 • 168 citations

Intensive combined therapy for previously untreated aggressive myeloma

1992 • 151 citations

Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis

1992 • 143 citations

Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell Transplantation

1998 • 121 citations

STERILISATION BY HYSTERECTOMY

1970 • 109 citations

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry

1998 • 88 citations

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

1997 • 72 citations

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C‐VAMP) as induction treatment followed by autografting in previously untreated myeloma

1997 • 61 citations

Impact of response to treatment on survival in multiple myeloma: results in a series of 243 patients

1994 • 58 citations

Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia.

1998 • 50 citations

Assessment of IgH PCR strategies in multiple myeloma.

1996 • 48 citations

Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation

1999 • 45 citations

Kinetics of paraprotein clearance after autografting for multiple myeloma.

1995 • 22 citations

Presentation of tumor antigens.

1999 • 12 citations

Cited By (0)

Loading...
The impact of attaining a minimal disease state after high‐dose melphalan and autologous… (2001) – British Journal of Haematology | Metascience Observatory Explorer